Sobi to advance Gamifant® (emapalumab) in interferon-gamma-driven sepsis (IDS) based on EMBRACE topline data

Sobi® (STO: SOBI) today announced that topline results from the Phase 2a EMBRACE study evaluating Gamifant® (emapalumab) for interferon-gamma (IFNγ)-driven sepsis (IDS), showed proof-of-concept with ...

Swedish Orphan Biovitrum AB: Sobi to advance Gamifant (emapalumab) in interferon-gamma-driven sepsis (IDS) based on EMBRACE topline data

Sobi (STO: SOBI) today announced that topline results from the Phase 2a EMBRACE study evaluating Gamifant (emapalumab) for interferon-gamma (IFN?)-driven ...

New evidence for a particle system that 'remembers' its previous quantum states

In the future, quantum computers are anticipated to solve problems once thought unsolvable, from predicting the course of ...

Plasma rings around M dwarf stars offer new clues to planetary habitability

How does a star affect the makeup of its planets? And what does this mean for the habitability of distant worlds? Carnegie's ...